Literature DB >> 16891795

Expression of CD44 adhesion molecule in rat testis with ischemia/reperfusion injury.

Changjong Moon1, Chan-woo Jeong, Heechul Kim, Meejung Ahn, Seungjoon Kim, Taekyun Shin.   

Abstract

The expression pattern of CD44 was studied in the rat testis following ischemia/reperfusion (I/R) injury to elucidate the possible role of the CD44 adhesion molecule in acute experimental testicular torsion. Western blot analysis showed that CD44 expression began to increase significantly 24 hr after reperfusion, compared with the normal control; the increased expression persisted until 96 hr after I/R. Immunohistochemistry showed that, in the normal testis, CD44 was constitutively expressed mainly in ED2-positive resident macrophages in the interstitial space. After I/R, the majority of inflammatory cells in the interstitial space surrounding the damaged tubules were ED1-positive macrophages that were CD44-positive. These findings suggest that the significant increase in CD44 expression that occurs during the delayed phase after reperfusion originates from infiltrating macrophages possibly in anticipation of the migration and adhesion of additional macrophages into the affected testis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891795     DOI: 10.1292/jvms.68.761

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

Review 1.  Mechanisms of testicular torsion and potential protective agents.

Authors:  Ersagun Karaguzel; Mustafa Kadihasanoglu; Omer Kutlu
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

2.  CD44 expression in renal ischemia-reperfusion injury in rats.

Authors:  Burak Kocak; Taner Orug; Nesrin Turhan; Necdet Ozcay; Faruk Gonenc
Journal:  Int Urol Nephrol       Date:  2009-03-13       Impact factor: 2.370

3.  CD44 disruption attenuates murine hepatic ischemia/reperfusion injury.

Authors:  Min Sung Kim; Ki Ho Lee; Won Mee Lee; Jin Hyun Jun; Dong Hee Kim
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.